Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NOE-115 by Noema Pharma for Vasomotor Symptoms of Menopause (Hot Flashes): Likelihood of Approval
NOE-115 is under clinical development by Noema Pharma and currently in Phase II for Vasomotor Symptoms of Menopause (Hot Flashes)....
Gemlapodect by Noema Pharma for Stammering (Stuttering): Likelihood of Approval
Gemlapodect is under clinical development by Noema Pharma and currently in Phase II for Stammering (Stuttering). According to GlobalData, Phase...
Gemlapodect by Noema Pharma for Tourette Syndrome: Likelihood of Approval
Gemlapodect is under clinical development by Noema Pharma and currently in Phase II for Tourette Syndrome. According to GlobalData, Phase...